308 related articles for article (PubMed ID: 20674446)
1. [Health related quality of life and endpoints in oncology].
Bonnetain F
Cancer Radiother; 2010 Oct; 14(6-7):515-8. PubMed ID: 20674446
[TBL] [Abstract][Full Text] [Related]
2. Endpoints in cancer clinical trials.
Fiteni F; Westeel V; Pivot X; Borg C; Vernerey D; Bonnetain F
J Visc Surg; 2014 Feb; 151(1):17-22. PubMed ID: 24440056
[TBL] [Abstract][Full Text] [Related]
3. Design and endpoints of clinical trials in hepatocellular carcinoma.
Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
[TBL] [Abstract][Full Text] [Related]
4. Poor correlation between progression-free and overall survival in modern clinical trials: are composite endpoints the answer?
Amir E; Seruga B; Kwong R; Tannock IF; Ocaña A
Eur J Cancer; 2012 Feb; 48(3):385-8. PubMed ID: 22115991
[TBL] [Abstract][Full Text] [Related]
5. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
Miller RG; Mitchell JD; Lyon M; Moore DH
Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
[TBL] [Abstract][Full Text] [Related]
6. Endpoints for assessing drug activity in clinical trials.
Pazdur R
Oncologist; 2008; 13 Suppl 2():19-21. PubMed ID: 18434634
[TBL] [Abstract][Full Text] [Related]
7. Interim futility analysis with intermediate endpoints.
Goldman B; LeBlanc M; Crowley J
Clin Trials; 2008; 5(1):14-22. PubMed ID: 18283075
[TBL] [Abstract][Full Text] [Related]
8. Use of progression-free survival as a surrogate marker in oncology trials: some regulatory issues.
Chakravarty A; Sridhara R
Stat Methods Med Res; 2008 Oct; 17(5):515-8. PubMed ID: 18285437
[TBL] [Abstract][Full Text] [Related]
9. Surrogate end points for median overall survival in metastatic colorectal cancer: literature-based analysis from 39 randomized controlled trials of first-line chemotherapy.
Tang PA; Bentzen SM; Chen EX; Siu LL
J Clin Oncol; 2007 Oct; 25(29):4562-8. PubMed ID: 17876010
[TBL] [Abstract][Full Text] [Related]
10. Placebo effect-adjusted assessment of quality of life in placebo-controlled clinical trials.
Eickhoff JC
Stat Med; 2008 Apr; 27(9):1387-402. PubMed ID: 18219702
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality-of-life as co-primary endpoint in randomized clinical trials in oncology.
Fiteni F; Pam A; Anota A; Vernerey D; Paget-Bailly S; Westeel V; Bonnetain F
Expert Rev Anticancer Ther; 2015; 15(8):885-91. PubMed ID: 26027598
[TBL] [Abstract][Full Text] [Related]
12. Quality of life measurements in oncology.
Lindley C
Pharmacotherapy; 1992; 12(4):346-52. PubMed ID: 1518733
[TBL] [Abstract][Full Text] [Related]
13. Use of meta-analysis for the validation of surrogate endpoints and biomarkers in cancer trials.
Buyse M
Cancer J; 2009; 15(5):421-5. PubMed ID: 19826362
[TBL] [Abstract][Full Text] [Related]
14. Quality of life in oncology trials: a clinical guide.
Movsas B
Semin Radiat Oncol; 2003 Jul; 13(3):235-47. PubMed ID: 12903013
[TBL] [Abstract][Full Text] [Related]
15. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
16. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
17. [Measurement of health-related quality of life in malignant diseases. Does it have any consequences?].
Wisløff F
Tidsskr Nor Laegeforen; 1997 Oct; 117(26):3812-6. PubMed ID: 9417687
[TBL] [Abstract][Full Text] [Related]
18. Quality-of-life outcomes in oncology.
Siddiqui F; Kachnic LA; Movsas B
Hematol Oncol Clin North Am; 2006 Feb; 20(1):165-85. PubMed ID: 16580562
[TBL] [Abstract][Full Text] [Related]
19. [Surrogate endpoints].
Hill C
Bull Cancer; 1999; 86(7-8):622-4. PubMed ID: 10477379
[TBL] [Abstract][Full Text] [Related]
20. Survival end point reporting in randomized cancer clinical trials: a review of major journals.
Mathoulin-Pelissier S; Gourgou-Bourgade S; Bonnetain F; Kramar A
J Clin Oncol; 2008 Aug; 26(22):3721-6. PubMed ID: 18669458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
